Skin Analytics

Skin Analytics is dedicated to revolutionizing dermatological assessments through its AI-powered system, DERM (Deep Ensemble for the Recognition of Malignancy). This innovative AI as a Medical Device (AIaMD) is designed to assist healthcare providers, particularly within the NHS, by enhancing the triaging process for patients with skin lesions. The application of AI allows for the effective identification of benign cases while prioritizing those that may be malignant, thereby addressing the pressing issue of long wait times and limited access to dermatological care.

The DERM system has demonstrated impressive accuracy, correctly identifying 97% of skin cancers and 75% of benign lesions. By leveraging advanced machine learning algorithms, it analyzes dermoscopic images to facilitate timely and accurate assessments. This capability is particularly vital in the context of the UK's increasing demand for dermatology services, where a shortage of specialists has led to growing patient waitlists.

The management team at Skin Analytics brings together experts from diverse fields, including AI, technology, and healthcare. Their collective goal is to create sustainable pathways for skin cancer detection and care, ensuring that individuals receive the proper attention they require. As of Q2 2024, DERM has assessed over 120,000 NHS patients, showcasing its effectiveness in streamlining dermatological services and improving patient outcomes.

For more information, explore their AI for Dermatology and NHS Case Studies sections. Additionally, insights from their Webinar: Demystifying AI in Dermatology delve into the practical applications of this technology in clinical settings.